Image

Stroke and Anxiety Reduction

Stroke and Anxiety Reduction

Non Recruiting
18-89 years
All
Phase N/A

Powered by AI

Overview

The purpose of this pilot study is to explore the impact that a structured anxiety reduction intervention program has on patients being discharged to home following an acute stroke in an academic medical center. Eligible participants will be screened and recruited by the research team through daily rounds. After completing the informed consent process, the research team will pull demographic information from the electronic health record (EHR) and REDCAP that includes ethnicity and support system. Participants will complete the Anxiety Screen Questionnaire (GAD-7 ANXIETY SURVEY) and will be provided with information regarding stroke support groups available with additional NYU Langone Health and the American Heart Association internet-based information regarding anxiety reduction (NYU Langone Health Anxiety Reduction Bundle). The participants will be encouraged to attend a stroke support group for 3 months and utilize the NYU Langone Health Anxiety Reduction Bundle provided. At the completion of the intervention (3 months), participants will be provided with the GAD-7 ANXIETY SURVEY again and a survey that includes open-ended questions and a program evaluation by email. Analysis will occur after final data is collected.

Eligibility

Inclusion Criteria:

  • Be diagnosed with an acute stroke
  • Able to speak, read and write in English
  • Not cognitively impaired, as per standard of care documentation in the EHR regarding mental status.
  • Discharged to home
  • Internet access including email
  • Willingness to participate in an anxiety reduction program
  • Length of hospital stay less than 5 days from the initial presentation of stroke symptoms
  • Must be medically stable

Exclusion Criteria:

  • Not diagnosed with an acute stroke
  • Unable to speak, read and write in English as this intervention is not available in other languages and at this time, funding is not available in order to have the resources provided translated or to have translation services available for these participants.
  • Not discharged to home
  • No internet access including email
  • Unwilling or unable to participate in an anxiety reduction program
  • Cognitively impaired
  • Length of hospital stay greater than 6 days from the initial presentation of stroke symptoms
  • Not medically stable

Study details
    Acute Stroke

NCT06013982

NYU Langone Health

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.